Loading…

Protocol - Pain Quality Descriptors (Neuropathic) - Adult

Add to My Toolkit
Description

The Patient-Reported Outcomes Measurement Information System (PROMIS®) Scale v2.0 - Neuropathic Pain Quality 5a is a self-administered questionnaire for individuals aged 18 years and older, assessing 5 descriptors of neuropathic pain quality, with a recall period of the past 7 days. This protocol was validated in individuals aged 18 years and older.

Specific Instructions

Because of validation in a wide range of ages, the PhenX Working Group (WG) recommends the use of the Patient-Reported Outcomes Measurement Information System (PROMIS®) Pain Quality Descriptors protocols if the study contains a broad range of ages or if the study will be tracking the same participant(s) through age transitions from childhood to adulthood. If the study involves only adults and a broader array of pain descriptors are desirable, the PhenX WG recommends the use of the Short Form-McGill Pain Questionnaire-2 (SF-MPQ-2) protocol.

The PhenX WG recommends this PROMIS® protocol. For additional information regarding PROMIS® instruments (including scoring, validity, and interpretation), please visit: www.healthmeasures.net. For specific information about this instrument, please visit:

https://www.healthmeasures.net/index.php?option=com_instruments&view=measure&id=783&Itemid=992

Protocol

PROMIS® Neuropathic Pain Quality 5a

Please respond to each question or statement by marking one box per row.

In the past 7 days…

Not at allA little bitSomewhatQuite a
bit
Very
much
Did your pain feel like pins and needles?...[ ]
1
[ ]
2
[ ]
3
[ ]
4
[ ]
5
Did your pain feel tingly?...[ ]
1
[ ]
2
[ ]
3
[ ]
4
[ ]
5
Did your pain feel stinging?...[ ]
1
[ ]
2
[ ]
3
[ ]
4
[ ]
5
Did your pain feel electrical?...[ ]
1
[ ]
2
[ ]
3
[ ]
4
[ ]
5
Did your pain feel numb?...[ ]
1
[ ]
2
[ ]
3
[ ]
4
[ ]
5

Availability

Available

Personnel and Training Required

None

Equipment Needs

None

Requirements
Requirement CategoryRequired
Major equipment No
Specialized training No
Specialized requirements for biospecimen collection No
Average time of greater than 15 minutes in an unaffected individual No
Mode of Administration

Self-administered questionnaire

Lifestage

Adult

Participants

Adults aged 18 years and older

Selection Rationale

The Patient-Reported Outcomes Measurement Information System (PROMIS®) Scale v2.0 - Neuropathic Pain Quality 5a item bank is psychometrically sound, validated, well established; has standardized scoring; and is easy to implement and interpret.

Language

English, French, Spanish

Standards
StandardNameIDSource
caDSR Common Data Elements (CDE) PROMIS v2.0 Neuropathic Pain Quality 5a PAQUAL27r Past Week Pain Felt Like Pins and Needles Score 5 Point Scale 8042082 CDE Browser
caDSR Common Data Elements (CDE) PROMIS v2.0 Neuropathic Pain Quality 5a PAQUAL14r Pain Felt Tingly Score 5 Point Scale 8042085 CDE Browser
caDSR Common Data Elements (CDE) PROMIS v2.0 Neuropathic Pain Quality 5a PAQUAL21r Pain Felt Stinging Score 5 Point Scale 8042086 CDE Browser
caDSR Common Data Elements (CDE) PROMIS v2.0 Neuropathic Pain Quality 5a PAQUAL31r Past Week Pain Felt Electrical Score 5 Point Scale 8042087 CDE Browser
caDSR Common Data Elements (CDE) PROMIS v2.0 Neuropathic Pain Quality 5a PAQUAL11r Past Week Pain Felt Numb Score 5 Point Scale 8042088 CDE Browser
Derived Variables

None

Process and Review

Not Applicable

Protocol Name from Source

Patient-Reported Outcomes Measurement Information System (PROMIS®) Scale v2.0 - Neuropathic Pain Quality 5a

Source

Askew, R. L., Cook, K. F., Keefe, F. J., Nowinski, C. J., Cella, D., Revicki, D. A., Morgan DeWitt, E. M., Michaud, K., Trence, D. L., & Amtmann, D. (2016). A PROMIS measure of neuropathic pain quality. Value in Health, 19(5), 623–630.

General References

Curtis, S. A., Brandow, A. M., DeVeaux, M., Zeltermam, D., Devine, L., & Roberts, J. D. (2020). Daily cannabis users with sickle cell disease show fewer admissions than others with similar pain complaints. Cannabis and Cannabinoid Research, 5(3), 255–262.

Revicki, D. A., Cook, K. F., Amtmann, D., Harnam, N., Chen, W. H., & Keefe, F. J. (2014). Exploratory and confirmatory factor analysis of the PROMIS pain quality item bank. Quality of Life Research, 23(1), 245–255.

Vaughan, B., Chase, B., Hickey, J., Tassoulas, M., Weston, H., Fitzgerald, K., Fleischmann, M., Mulcahy, J., & Austin, P. (2021). PROMIS neuropathic and nociceptive pain quality in musculoskeletal pain presentations. Clinical Journal of Pain, 37(9), 639–647.

Protocol ID

860704

Variables
Export Variables
Variable Name Variable IDVariable DescriptiondbGaP Mapping
Pain
Measure Name

Pain Quality Descriptors

Release Date

July 28, 2022

Definition

A measure used to assess the specific subjective sensations associated with pain.

Purpose

Assessing the nature of pain an individual experiences may assist in indicating whether the pain is primarily nociceptive or neuropathic. This can aid in the selection of appropriate treatment and in evaluating a patient's response to treatment.

Keywords

Pain, affective, sickle cell disease, SCD, pain quality, pain measurement, pain assessment, Patient-Reported Outcomes Measurement Information System, PROMIS®, National Institutes of Health, NIH, type I diabetes, asthma

Measure Protocols
Protocol ID Protocol Name
860701 Pain Quality Descriptors (Affective) - Children
860702 Pain Quality Descriptors (Sensory) - Children
860703 Pain Quality Descriptors (Nociceptive) - Adult
860704 Pain Quality Descriptors (Neuropathic) - Adult
Publications

There are no publications listed for this protocol.